Clinical Trials Directory

Trials / Terminated

TerminatedNCT03195530

Bispectral Index (BIS) Values Required for an Adequate Depth of Anesthesia in Elderly Patients Using Propofol

Bispectral Index (BIS) Values Required for an Adequate Depth of Anesthesia in Elderly Patients Using Propofol, According to the Characteristic Electroencephalographic Pattern

Status
Terminated
Phase
Study type
Observational
Enrollment
12 (actual)
Sponsor
Pontificia Universidad Catolica de Chile · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

A correlation between the bispectral index values and electroencephalographic patterns at the loss of consciousness (LOC) when using propofol in elderly patients, has not been determined. Our aim is to describe the BIS values and the power of the alpha band in the electroencephalography in elderly patients, at the LOC moment.

Detailed description

Propofol is an anesthetic drug regularly used in elderly patients requiring anesthesia. The electroencephalographic pattern recognized when propofol is administered, is different to the pattern obtained in younger patients. Both groups presents an alpha and slow bands, but they differ in the intensity of the signal. Younger patients presents more intense electroencephalographic bands than older patients. Bispectral index (BIS) is a clinical indicator used to evaluate the depth of anesthesia. A correlation between this indicator and the power of electroencephalographic bands has not been determined. We will describe the LOC moment of elderly patients receiving propofol as anesthetic for general surgery, with the EEG characteristic bands and the BIS value obtained at that moment. The BIS values related to the EEG characteristic bands can be described, to correlate the actual indicators of depth of anesthesia with new parameters.

Conditions

Interventions

TypeNameDescription
DRUGPropofolInduction of anesthesia using propofol, and recording the BIS values and EEG patterns during the induction

Timeline

Start date
2017-05-01
Primary completion
2018-01-31
Completion
2018-03-31
First posted
2017-06-22
Last updated
2018-04-11

Locations

1 site across 1 country: Chile

Source: ClinicalTrials.gov record NCT03195530. Inclusion in this directory is not an endorsement.